Hongxia Wang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis via MAPK signaling.

Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis via MAPK signaling.

Journal: Journal of translational internal medicine

Published: August 27, 2026

Bacterial internalins exploit E-cadherin to promote head and neck tumor metastasis and drug resistance.

Bacterial internalins exploit E-cadherin to promote head and neck tumor metastasis and drug resistance.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma.

Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma.

Journal: Life sciences

Published: November 02, 2025

RNARL: reinforcement learning-driven unified generative framework for multi-objective RNA codon design.

RNARL: reinforcement learning-driven unified generative framework for multi-objective RNA codon design.

Journal: Genome biology

Published: October 21, 2025

Cancer-Associated Fibroblasts Functions as Multifunctional Architects of the Tumor Stroma and Represent Emerging Therapeutic Vulnerabilities.

Cancer-Associated Fibroblasts Functions as Multifunctional Architects of the Tumor Stroma and Represent Emerging Therapeutic Vulnerabilities.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 31, 2025

Real-world application of 18F-FES PET/CT on HR + breast cancer patients with brain metastases.

Real-world application of 18F-FES PET/CT on HR + breast cancer patients with brain metastases.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 07, 2025

Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy.

Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy.

Journal: Precision clinical medicine

Published: July 19, 2025

Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways.

Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways.

Journal: Cancer cell

Published: June 04, 2025

A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.

A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.

Journal: Future oncology (London, England)

Published: December 04, 2024

Transcriptome Landscape of Cancer-Associated Fibroblasts in Human PDAC.

Transcriptome Landscape of Cancer-Associated Fibroblasts in Human PDAC.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 18, 2024

Cancer stem cells-derived exosomal TSPAN8 enhances non-stem cancer cells stemness and promotes malignant progression in PDAC.

Cancer stem cells-derived exosomal TSPAN8 enhances non-stem cancer cells stemness and promotes malignant progression in PDAC.

Journal: Oncogene

Published: October 18, 2024

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.

Journal: Molecular cancer

Published: October 09, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026